Analysis of SERPING1 expression on hereditary angioedema patients: Quantitative analysis of full-length and exon 3 splicing variants

Immunology Letters

Volumn 141, Issue 2, 2012, Pages 158-164

  Mena de la Cruz, Rocío ^a,b   López Lera, Alberto ^a,b   López Trascasa, Margarita ^a,b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Alternative splicing; C1 inhibitor; Hereditary angioedema; RT qPCR

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; MESSENGER RNA;

AMPLICON; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXON; EXON SKIPPING; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE PRODUCT; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA SPLICING; SERPING1 GENE; TRANSCRIPTION REGULATION;

ADOLESCENT; ADULT; ALTERNATIVE SPLICING; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INACTIVATOR PROTEINS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEIN ISOFORMS; SPAIN;

EID: 84855928907     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.07.011     Document Type: Article

References (27)

1. Agostoni A., Aygören-Pürsün E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004, 114(September (3 Suppl.)):S51-S131.
2. Papadopoulou-Alataki E. Upper airway considerations in hereditary angioedema. Curr Opin Allergy Clin Immunol 2010, 10(1):20-25.
3. Beinrohr L., Dobó J., Závodszky P., Gál P. C1 MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends Mol Med 2008, 14(12):511-521.
4. Cugno M., Nussberger J., Cicardi M., Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 2003, 3(3):311-317.
5. Davis A.E., Mejia P., Lu F. Biological activities of C1 inhibitor. Mol Immunol 2008, 45(16):4057-4063. Review.
6. Bos I.G., Hack C.E., Abrahams J.P. Structural and functional aspects of C1-inhibitor. Immunobiology 2002, 205(4-5):518-533.
7. Bissler J.J., Aulak K.S., Donaldson V.H., Rosen F.S., Cicardi M., Harrison R.A., et al. Molecular defects in hereditary angioneurotic edema. Proc Assoc Am Phys 1997, 109(2):164-173.
8. Blanch A., Roche O., López-Granados E., Fontán G., López-Trascasa M. Detection of C1 inhibitor (SERPING1/C1NH) mutations in exon 8 in patients with hereditary angioedema: evidence for 10 novel mutations. Hum Mutat 2002, Mutation in Brief #544, Online.
9. Roche O., Blanch A., Duponchel C., Fontán G., Tosi M., López-Trascasa M. Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort. Hum Mutat 2005, 26(2):135-144.
10. Pappalardo E., Caccia S., Suffritti C., Tordai A., Zingale L.C., Cicardi M. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol 2008, 45(13):3536-3544.
11. Kramer J., Rosen F.S., Colten H.R., Rajczy K., Strunk R.C. Transinhibition of C1 inhibitor synthesis in Type I hereditary angioneurotic edema. J Clin Invest 1993, 91(March (3)):1258-1262.
12. Verpy E., Couture-Tosi E., Tosi M. C1 inhibitor mutations which affect intracellular transport and secretion in Type I hereditary angioedema. Behring Inst Mitt 1993, 120-124.
13. Pappalardo E., Zingale L.C., Cicardi M. C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol 2004, 114(3):638-644.
14. Roche O. Angioedema hereditario: Mutaciones puntuales de los exones 1 al 7 en el gen del C1-inhibidor, Registro español de la enfermedad. PhD Thesis. Universidad Autónoma de Madrid; 2005.
15. Duponchel C., Djenouhat K., Frémeaux-Bacchi V., Monnier N., Drouet C., Tosi M. Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH. Hum Mutat 2006, 27(3):295-296.
16. López-Lera A., Garrido S., Roche O., López-Trascasa M. SERPING1 mutations in 59 families with hereditary angioedema. Mol. Immunol. 2011, 10.1016/j.molimm.2011.07.010.
17. Pappalardo E., Zingale L.C., Cicardi M. Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol. Immunol Lett 2003, 86:271-276.
18. Brogna S., Wen J. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat Struct Mol Biol 2009 Feb, 16(2):107-113.
19. Bos I.G.A., Lubbers Y.T.P., Roem D., Abrahams J.P., Hack C.E., Eldering E. The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant. J Biol Chem 2003, 278(32):29463-29470.
20. Lareau L.F., Brooks A.N., Soergel D.A., Meng Q., Brenner S.E. The coupling of alternative splicing and nonsense-mediated mRNA decay. Adv Exp Med Biol 2007, 623:190-211.
21. Nissim-Rafinia M., Kerem B. The splicing machinery is a genetic modifier of disease severity. Trends Genet 2005, 21(9):480-483.
22. Modrek B., Lee C.A. Genomic view of alternative splicing. Nat Genet 2002, 30(1):13-19.
23. Hammond S.M., Wood M.J. Genetic therapies for RNA mis-splicing diseases. Trends Genet 2011, 27(5):196-205.
24. Venables J.P. Unbalanced alternative splicing and its significance in cancer. Bioessays 2006, 28(4):378-386.
25. Cáceres J.F., Kornblihtt A.R. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 2002, 18(4):186-193.
26. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009, 10(11):741-754.
27. Häsler R., Kerick M., Mah N., Hultschig C., Richter G., Bretz F., et al. Alterations of pre-mRNA splicing in human inflammatory bowel disease. Eur J Cell Biol 2011, 90(6-7):603-611.